Published in J Chem Soc Perkin 1 on January 01, 1977
Pseudomonas syringae phytotoxins: mode of action, regulation, and biosynthesis by peptide and polyketide synthetases. Microbiol Mol Biol Rev (1999) 3.83
Mechanism of mupirocin transport into sensitive and resistant bacteria. Antimicrob Agents Chemother (1989) 1.32
Resistance to and synthesis of the antibiotic mupirocin. Nat Rev Microbiol (2010) 1.21
Characterization and transcriptional analysis of the gene cluster for coronafacic acid, the polyketide component of the phytotoxin coronatine. Appl Environ Microbiol (1995) 0.95
Analysis of genes involved in biosynthesis of coronafacic acid, the polyketide component of the phytotoxin coronatine. J Bacteriol (1998) 0.92
Biosynthesis of the Pseudomonas polyketide coronafacic acid requires monofunctional and multifunctional polyketide synthase proteins. Proc Natl Acad Sci U S A (1998) 0.91
The use of Tween 20 as a blocking agent in the immunological detection of proteins transferred to nitrocellulose membranes. J Immunol Methods (1982) 6.36
Microstructural maturation of the human brain from childhood to adulthood. Neuroimage (2008) 5.30
Multicenter evaluation of the BDProbeTec ET System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs. J Clin Microbiol (2001) 4.92
Disulfide-linked oligomers of the major outer membrane protein of chlamydiae. J Bacteriol (1983) 4.91
THE MAINTENANCE OF A NORMAL PLASMA PROTEIN CONCENTRATION IN SPITE OF REPEATED PROTEIN LOSS BY BLEEDING. J Exp Med (1932) 4.75
Analysis of the human serological response to proteins of Chlamydia trachomatis. Infect Immun (1982) 4.57
Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (1998) 4.19
Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measles. JAMA (1999) 3.77
Diagnosis of chlamydial infection in women attending antenatal and gynecologic clinics. J Clin Microbiol (1987) 3.70
Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis. J Clin Microbiol (2000) 3.44
Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4. J Biol Chem (2000) 3.37
A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. N Engl J Med (1992) 3.18
Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis (1997) 2.98
Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae. J Clin Microbiol (2000) 2.80
Nonculture tests for genital tract chlamydial infection. What does the package insert mean, and will it mean the same thing tomorrow? Sex Transm Dis (1992) 2.80
Fournier's syndrome: necrotizing subcutaneous infection of the male genitalia. J Urol (1979) 2.46
Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Escherichia coli by pseudomonic acid. Biochem J (1978) 2.41
Rearrangement and transcription of the beta-chain genes of the T-cell antigen receptor in different types of murine lymphocytes. Nature (1985) 2.29
Phylogenetic analysis of the Chlamydia trachomatis major outer membrane protein and examination of potential pathogenic determinants. Infect Immun (1998) 2.27
Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetase. Biochem J (1980) 2.24
Effect of blind passage and multiple sampling on recovery of Chlamydia trachomatis from urogenital specimens. J Clin Microbiol (1986) 2.22
Fluorescent monoclonal antibody for confirmation of Neisseria gonorrhoeae cultures. J Clin Microbiol (1987) 2.21
Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment. Arthritis Rheum (2006) 2.14
Recurrent genitourinary chlamydial infections in sexually active female adolescents. J Pediatr (1992) 2.13
Use of smokeless tobacco in the 1986 World Series. N Engl J Med (1987) 2.08
Chlamydia trachomatis in the pharynx and rectum of heterosexual patients at risk for genital infection. Ann Intern Med (1985) 2.06
Serovar determination of Chlamydia trachomatis isolates by using type-specific monoclonal antibodies. J Clin Microbiol (1986) 2.06
Pseudomonic acid: an antibiotic produced by Pseudomonas fluorescens. Nature (1971) 2.05
Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J Clin Microbiol (2000) 2.02
Hyperosmolar dehydration in infancy due to faulty feeding. Arch Dis Child (1972) 2.00
Relation of surgical volume to outcome in eight common operations: results from the VA National Surgical Quality Improvement Program. Ann Surg (1999) 1.98
Effect of prior sexually transmitted disease on the isolation of Chlamydia trachomatis. Sex Transm Dis (1987) 1.95
Reducing non-attendance in an outpatient clinic. Public Health (1988) 1.92
A critical review of fear tests used on cattle, pigs, sheep, poultry and horses. Physiol Behav (2007) 1.91
A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med (1995) 1.89
Differences in outer membrane proteins of the lymphogranuloma venereum and trachoma biovars of Chlamydia trachomatis. Infect Immun (1985) 1.84
SK&F 75073, new parenteral broad-spectrum cephalosporin with high and prolonged serum levels. Antimicrob Agents Chemother (1978) 1.81
A computer-assisted register and information system for diabetes. Methods Inf Med (1983) 1.80
Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: their interrelationship and prediction of survival. Am J Kidney Dis (1995) 1.74
Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results. J Clin Microbiol (2001) 1.73
B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study. Clin Otolaryngol (2009) 1.67
Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol (2001) 1.67
Correlation between serum antichlamydial antibodies and tubal factor as a cause of infertility. Fertil Steril (1982) 1.67
On the mode of action of pseudomonic acid: inhibition of protein synthesis in Staphylococcus aureus. J Antibiot (Tokyo) (1978) 1.67
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med (1988) 1.67
Correlation of infecting serovar and local inflammation in genital chlamydial infections. J Infect Dis (1989) 1.65
Censoring of patient-held records by doctors. J R Coll Gen Pract (1988) 1.62
White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy. AJNR Am J Neuroradiol (1998) 1.59
Defining the relationship between obesity and total joint arthroplasty. Obes Res (2001) 1.58
Cost-effectiveness of culturing for Chlamydia trachomatis. A study in a clinic for sexually transmitted diseases. Ann Intern Med (1986) 1.57
Interferon-gamma in endocervical secretions of women infected with Chlamydia trachomatis. J Infect Dis (1990) 1.57
Identification of a Chlamydia trachomatis serovar E urogenital isolate which lacks the cryptic plasmid. Infect Immun (1998) 1.56
Treatment of hyperthyroidism by radioactive iodine. Summary of a UK national survey prepared for the Royal College of Physicians Committee on Endocrinology and Diabetes. J R Coll Physicians Lond (1992) 1.56
In-vitro comparison of erythromycin, lincomycin, and clindamycin. Br Med J (1970) 1.54
Natural language generation in health care. J Am Med Inform Assoc (1997) 1.51
Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem. Front Immunol (2012) 1.50
Nonpredictable pharmacokinetic behavior of high-dose cyclophosphamide in combination with cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea. Clin Cancer Res (1999) 1.43
Characterization of the specificity of peptide binding to four DR haplotypes. J Immunol (1990) 1.43
Hypersensitivity to Colchicine. Ann Rheum Dis (1947) 1.41
Efficiency and cost-effectiveness of field follow-up for patients with Chlamydia trachomatis infection in a sexually transmitted diseases clinic. Sex Transm Dis (1988) 1.40
Acute encephalopathy: a new toxicity associated with high-dose paclitaxel. Clin Cancer Res (1999) 1.40
High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol (1988) 1.40
Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Intensive Care Antimicrobial Resistance Epidemiology Project and National Nosocomial Infections Surveillance System Hospitals. Infect Control Hosp Epidemiol (1998) 1.39
Dissemination and commercialization of hematopoietic progenitor cell transplantation. J Hematother (1994) 1.39
Galactic and Extragalactic Studies: IX. A Photometric Survey of 22,000 Galaxies in the Zone from delta = +41 degrees to delta = +46 degrees. Proc Natl Acad Sci U S A (1940) 1.38
Compliance with antibiotic therapy for Chlamydia trachomatis and Neisseria gonorrhoeae. Sex Transm Dis (1993) 1.38
What really happens to people on long-term peritoneal dialysis? Kidney Int (1998) 1.37
Recovery of Chlamydia trachomatis from the endometrium of women at risk for chlamydial infection. Am J Obstet Gynecol (1986) 1.37
Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant (1996) 1.37
Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. J Infect Dis (2000) 1.36
Quantitative culture of endocervical Chlamydia trachomatis. J Clin Microbiol (1990) 1.34
Patient-held records: censoring of information by doctors. J R Coll Physicians Lond (1987) 1.33
Association of recurrent chlamydial infection with gonorrhea. J Infect Dis (1989) 1.33
Prophylactic activity of cephalosporins in a mouse model of surgical wound infection. J Antibiot (Tokyo) (1983) 1.32
Chlamydial infections. Annu Rev Med (1988) 1.30
The pharmacokinetics of temocillin in patients with normal and impaired renal function. J Antimicrob Chemother (1983) 1.30
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT. Bone Marrow Transplant (2009) 1.27
A review of the metabolism and pharmacokinetics of paroxetine in man. Acta Psychiatr Scand Suppl (1989) 1.26
Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs. Biochemistry (2001) 1.26
Lying to military physicians about risk factors for HIV infections. JAMA (1987) 1.26
Focused interviewing in gonorrhea control. Am J Public Health (1980) 1.26
The relationship between paroxetine and the sparteine oxidation polymorphism. Clin Pharmacol Ther (1992) 1.26
Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol (1994) 1.26
Detection of surface-exposed epitopes on Chlamydia trachomatis by immune electron microscopy. J Gen Microbiol (1989) 1.25
Phase I trial of XR9576 in healthy volunteers demonstrates modulation of P-glycoprotein in CD56+ lymphocytes after oral and intravenous administration. Clin Cancer Res (2000) 1.24
Comparative evaluation of media for isolation of ureaplasma urealyticum and genital mycoplasma species. J Clin Microbiol (1982) 1.24
Laboratory studies with cefatrizine (SK + F 60771), a new broad-spectrum orally-active cephalosporin. J Antibiot (Tokyo) (1975) 1.24
A new parenteral cephalosporin. SK&F 59962: in vitro and in vivo antibacterial activity and serum levels in experimental animals. J Antibiot (Tokyo) (1975) 1.22
Stress reactivity of the brain noradrenergic system in three rat strains differing in their neuroendocrine and behavioral responses to stress: implications for susceptibility to stress-related neuropsychiatric disorders. Neuroscience (2002) 1.21
Subacute chlamydial endocarditis. JAMA (1982) 1.21
Antigenic analysis of the major outer membrane protein of Chlamydia trachomatis with murine monoclonal antibodies. Infect Immun (1986) 1.20
Monoclonal antibodies to the Ca2+ + Mg2+-dependent ATPase of sarcoplasmic reticulum identify polymorphic forms of the enzyme and indicate the presence in the enzyme of a classical high-affinity Ca2+ binding site. J Bioenerg Biomembr (1984) 1.19
Ethics and early intervention in psychosis: keeping up the pace and staying in step. Schizophr Res (2001) 1.19
Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer. Br J Cancer (2011) 1.18
Pseudomonic acid. Part 1. The structure of pseudomonic acid A, a novel antibiotic produced by Pseudomonas fluorescens. J Chem Soc Perkin 1 (1977) 1.18
Cefoxitin in the treatment of gonorrhea. Sex Transm Dis (1980) 1.18
Gender differential in all-cause and cardiovascular disease mortality. Int J Epidemiol (1993) 1.17
Insulin-like effect of pinitol. Br J Pharmacol (2000) 1.17
Purification and antigenic relatedness of proteins II of Neisseria gonorrhoeae. Infect Immun (1985) 1.14